Fluoguide: Wrap up from interview with CEO Morten Albrechtsen
In this interview CEO Morten Albrechtsen briefly run through the Equity story and why FG001(illumination) from their unique U-par technology is enhancing precision guided surgery. Further the topic is Fluoguide's partnership structure and what investors should look for after the recent announcement regarding the collaborative deal with Intuitive Surgical a pioneer within robot surgery.
Beneath you find interesting slides from the presentation:
Potential Partners:
Partnership matrix:
Watch the event here: Fluoguide interview
Disclaimer: HC Andersen Capital receives payment from Fluoguide for a Digital IR/Corporate Visibility subscription agreement. /Claus Thestrup 08:25 AM 21-03-2024.
Sisäänkirjautuminen vaadittu
Tämä sisältö on näkyvissä vain sisäänkirjautuneille käyttäjille
FluoGuide
FluoGuide is a Danish company active in medical technology. The company's business focus is found in research and development of treatments against various forms of cancer, with the greatest focus on the development of products that guide surgical interventions. The products bind to the cancer cells, which then light up and are intended to be used to precisely remove harmful tumors in the patient's tissue.
Lue lisää yhtiösivulla